Related Experiment Videos
New prognostic factors in resectable non-small cell lung cancer
E F Smit1, H J Groen, T A Splinter
1Department of Pulmonary Diseases, University Hospital Groningen, Netherlands.
Thorax
|June 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study.
Lung cancer (Amsterdam, Netherlands)·2025
Liquid biopsy in BALF is now suitable for clinical practice in patients with suspected NSCLC.
Lung cancer (Amsterdam, Netherlands)·2025
Pooled analysis of trastuzumab deruxtecan retreatment after recovery from grade 1 interstitial lung disease/pneumonitis.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Combined analysis of circulating tumor DNA and tumor tissue to overcome osimertinib resistance (OSIRIS); the second line osimertinib cohort.
Lung cancer (Amsterdam, Netherlands)·2024
Integrated noninvasive diagnostics for prediction of survival in immunotherapy.
Immuno-oncology technology·2024
Cell cycle-dependent translation-mediated turnover of the long noncoding RNA Malat1.
The Journal of cell biology·2026
Generation of a New Immunodeficient Rat Model of Retinal Degeneration With LSL TdTomato Reporter and TdTomato-Pcp2 Expression.
Translational vision science & technology·2026
Multiplexed Profiling of Individual Extracellular Vesicles Reveals Lung Cancer-Associated Protein Signatures.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
The Tumor Microenvironment Score and Its Subsite-Specific Relevance in Colon Cancer.
The American journal of surgical pathology·2026
Plasma ACTH Precursors measured by Pro-opiomelanocortin (POMC) ELISA as a Predictor of Silent Corticotroph Adenomas.
The Journal of clinical endocrinology and metabolism·2026